Halozyme Therapeutics shares owned by Bank of New York Mellon
Quarter-by-quarter ownership of Halozyme Therapeutics shares owned by Bank of New York Mellon
from 13F filings
Historical chart of Bank of New York Mellon investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Bank of New York Mellon consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Bank of New York Mellon
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $231k | 200k | 1.16 |
| 2025-06-30 | $299k | 300k | 1.00 |
| 2025-03-31 | $637k | 600k | 1.06 |
| 2024-12-31 | $191k | 200k | 0.95 |
| 2024-09-30 | $702k | 700k | 1.00 |
| 2024-06-30 | $571k | 600k | 0.95 |
| 2024-03-31 | $533k | 600k | 0.89 |
| 2023-12-31 | $518k | 600k | 0.86 |
| 2023-03-31 | $271k | 320k | 0.85 |
| 2022-12-31 | $584k | 600k | 0.97 |
| 2022-09-30 | $682k | 800k | 0.85 |
| 2022-06-30 | $712k | 800k | 0.89 |
| 2022-03-31 | $702k | 800k | 0.88 |